Literature DB >> 12515312

Effect of flumazenil on GABAA receptors in isolated rat hippocampal neurons.

Michel Weiss1, Denis Tikhonov, Svetlana Buldakova.   

Abstract

Using whole cell patch-clamp recordings from pyramidal cells acutely dissociated from rat hippocampal slices, Ro-15 1788 (flumazenil, FLU) was shown to enhance the GABAA-receptor mediated currents evoked by application of gamma-aminobutyric acid (GABA) and to antagonize the enhancing effect of the benzodiazepine agonist flurazepam (FZP) on the GABAA response. Both FLU and FZP increased the peak and the steady-state components of the responses and accelerated the current decay. This suggests that both agents act via a common mechanism on GABA transmission. It is concluded that FLU possesses high affinity for the binding site, but low efficacy on the GABAA-benzodiazepine receptor. This suggests that FLU acts as a partial agonist on GABAA receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12515312     DOI: 10.1023/a:1021674708556

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

Review 1.  International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function.

Authors:  E A Barnard; P Skolnick; R W Olsen; H Mohler; W Sieghart; G Biggio; C Braestrup; A N Bateson; S Z Langer
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

Review 2.  The benzodiazepine binding site of GABAA receptors.

Authors:  E Sigel; A Buhr
Journal:  Trends Pharmacol Sci       Date:  1997-11       Impact factor: 14.819

3.  A simple perfusion system for patch-clamp studies.

Authors:  V S Vorobjev; I N Sharonova; H L Haas
Journal:  J Neurosci Methods       Date:  1996-10       Impact factor: 2.390

4.  Electrophysiological evidence for agonist properties of flumazenil, a benzodiazepine receptor antagonist, in rat hippocampus slices.

Authors:  S Buldakova; M Weiss
Journal:  J Neurol Sci       Date:  1997-08       Impact factor: 3.181

5.  Reduction of inhibition by a benzodiazepine antagonist, Ro15-1788, in the rat hippocampal slice.

Authors:  G L King; J J Knox; R Dingledine
Journal:  Neuroscience       Date:  1985-06       Impact factor: 3.590

6.  Functional GABAA receptor heterogeneity of acutely dissociated hippocampal CA1 pyramidal cells.

Authors:  E I Tietz; J Kapur; R L Macdonald
Journal:  J Neurophysiol       Date:  1999-04       Impact factor: 2.714

Review 7.  Drug interactions at the GABA receptor-ionophore complex.

Authors:  R W Olsen
Journal:  Annu Rev Pharmacol Toxicol       Date:  1982       Impact factor: 13.820

8.  Benzodiazepine antagonists reduce epileptiform discharges in rat hippocampal slices.

Authors:  P Polc; S S Jahromi; G Facciponte; M R Pelletier; L Zhang; P L Carlen
Journal:  Epilepsia       Date:  1996-10       Impact factor: 5.864

9.  Benzodiazepine Ro 15-1788: electrophysiological evidence for partial agonist activity.

Authors:  J H Skerritt; R L Macdonald
Journal:  Neurosci Lett       Date:  1983-12-30       Impact factor: 3.046

10.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

View more
  10 in total

1.  Stress sensitization of ethanol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist.

Authors:  George R Breese; Darin J Knapp; David H Overstreet
Journal:  Neuropsychopharmacology       Date:  2004-03       Impact factor: 7.853

2.  Analysis of the excitatory and inhibitory components of postsynaptic currents recorded in pyramidal neurons and interneurons in the rat hippocampus.

Authors:  S L Buldakova; D B Tikhonov; L G Magazanik
Journal:  Neurosci Behav Physiol       Date:  2005-10

3.  Modulation of ethanol withdrawal-induced anxiety-like behavior during later withdrawals by treatment of early withdrawals with benzodiazepine/gamma-aminobutyric acid ligands.

Authors:  Darin J Knapp; David H Overstreet; George R Breese
Journal:  Alcohol Clin Exp Res       Date:  2005-04       Impact factor: 3.455

4.  The dual modulatory effects of efavirenz on GABAA receptors are mediated via two distinct sites.

Authors:  Renqi Huang; Zhenglan Chen; Sean Dolan; John A Schetz; Glenn H Dillon
Journal:  Neuropharmacology       Date:  2017-04-27       Impact factor: 5.250

5.  Behavioral effects of flumazenil in the social conflict test in mice.

Authors:  L Uhlírová; M Sustková-Fiserová; M Krsiak
Journal:  Psychopharmacology (Berl)       Date:  2003-09-05       Impact factor: 4.530

6.  Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypes.

Authors:  Stephanie C Licata; Donna M Platt; Daniela Rüedi-Bettschen; John R Atack; Gerard R Dawson; Michael L Van Linn; James M Cook; James K Rowlett
Journal:  Neuropharmacology       Date:  2009-10-22       Impact factor: 5.250

Review 7.  Pharmacological Modulation of GABA Function in Autism Spectrum Disorders: A Systematic Review of Human Studies.

Authors:  Natascia Brondino; Laura Fusar-Poli; Cristina Panisi; Stefano Damiani; Francesco Barale; Pierluigi Politi
Journal:  J Autism Dev Disord       Date:  2016-03

8.  Endogenous positive allosteric modulation of GABA(A) receptors by diazepam binding inhibitor.

Authors:  Catherine A Christian; Anne G Herbert; Rebecca L Holt; Kathy Peng; Kyla D Sherwood; Susanne Pangratz-Fuehrer; Uwe Rudolph; John R Huguenard
Journal:  Neuron       Date:  2013-05-30       Impact factor: 17.173

9.  Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy.

Authors:  Claire Leroy; Pierrick Poisbeau; A Florence Keller; Astrid Nehlig
Journal:  J Physiol       Date:  2004-03-19       Impact factor: 5.182

10.  [11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levels.

Authors:  W Gordon Frankle; Raymond Y Cho; N Scott Mason; Chi-Min Chen; Michael Himes; Christopher Walker; David A Lewis; Chester A Mathis; Rajesh Narendran
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.